WO2008068600A3 - An improved process for the preparation of zaleplo - Google Patents
An improved process for the preparation of zaleplo Download PDFInfo
- Publication number
- WO2008068600A3 WO2008068600A3 PCT/IB2007/003787 IB2007003787W WO2008068600A3 WO 2008068600 A3 WO2008068600 A3 WO 2008068600A3 IB 2007003787 W IB2007003787 W IB 2007003787W WO 2008068600 A3 WO2008068600 A3 WO 2008068600A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preparation
- improved process
- zaleplo
- formula
- zaleplon
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to an improved process for the preparation of N-[3-(3-cyanopyrazolo[ 1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide (Zaleplon) of formula (I), more particularly the present invention relates to a method for the purification of Zaleplon of formula (I), which is useful in medicine as an anxiolytic, sedative and skeletal muscle relaxing agent. Formula (I)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2255CH2006 | 2006-12-06 | ||
IN2255/CHE/2006 | 2006-12-06 | ||
IN701/CHE/2007 | 2007-04-03 | ||
IN701CH2007 | 2007-04-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008068600A2 WO2008068600A2 (en) | 2008-06-12 |
WO2008068600A3 true WO2008068600A3 (en) | 2008-08-07 |
Family
ID=39492679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2007/003787 WO2008068600A2 (en) | 2006-12-06 | 2007-12-06 | An improved process for the preparation of zaleplo |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008068600A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105622615A (en) * | 2015-12-30 | 2016-06-01 | 上海天慈国际药业有限公司 | Novel method for synthesizing zaleplon |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0208846A1 (en) * | 1983-06-23 | 1987-01-21 | American Cyanamid Company | [7-(3-Disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines |
EP0776898A1 (en) * | 1995-12-01 | 1997-06-04 | American Cyanamid Company | Process improvement in the synthesis of N-[3-(3-cyanopyrazolo [1,5-a]pyrimidin-7-yl)phenyl]-N-ethyl-acetamide |
-
2007
- 2007-12-06 WO PCT/IB2007/003787 patent/WO2008068600A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0208846A1 (en) * | 1983-06-23 | 1987-01-21 | American Cyanamid Company | [7-(3-Disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines |
EP0776898A1 (en) * | 1995-12-01 | 1997-06-04 | American Cyanamid Company | Process improvement in the synthesis of N-[3-(3-cyanopyrazolo [1,5-a]pyrimidin-7-yl)phenyl]-N-ethyl-acetamide |
Also Published As
Publication number | Publication date |
---|---|
WO2008068600A2 (en) | 2008-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200745121A (en) | Chemical compound | |
MX337817B (en) | PYRAZOLO[1,5-a]PYRIMIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES. | |
WO2007120752A3 (en) | 4, 5-dihydro- [1, 2, 4] triazolo [4, 3-f] pteridines as protein kinase plk1 inhibitors for the treatment of proliferative disorders | |
HK1202113A1 (en) | Short-acting benzodiazepine salts and their polymorphic forms | |
TW200613305A (en) | Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one | |
WO2011064171A3 (en) | Method for producing methyl-{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate and its purification for use thereof as pharmaceutical substance | |
WO2005020920A3 (en) | Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor | |
MEP60208A (en) | Phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor | |
MX2010006748A (en) | PYRAZOLO [1,5-a] PYRIMIDINES USEFUL AS JAK2 INHIBITORS. | |
GB0613693D0 (en) | Benzodiazepine salts (3) | |
WO2008070313A3 (en) | 3-(dihydro-1h-pyrazolo [4,3-d] pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use | |
WO2011064156A3 (en) | Method for producing methyl-{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl} carbamate and its purification for use thereof as pharmaceutical substance | |
PL374176A1 (en) | Process for purifying n-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the process | |
WO2008024151A3 (en) | Salts and co-crystals of pyrazolopyrimidine compounds, compositions thereof and methods for their production and use | |
PL372942A1 (en) | Process for the production of n-[3-(3-cyanopyrazolo[1,5-a] pyrimidin-7-yl)phenyl]-n-ethylacetamide (zaleplon) | |
TW200942546A (en) | A crystalline form of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one | |
WO2002012244A3 (en) | Polymorphs of zaleplon and methods for the preparation thereof | |
WO2008068600A3 (en) | An improved process for the preparation of zaleplo | |
MX2009003571A (en) | Polymorph b of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1 ,5-a] pyrimidin-7-yl]-phenyl}-n-methyl-acetamide. | |
WO2007136692A3 (en) | Crystalline forms of 5-chloro-6- (2, 6-difluoro-4- [3- (methylamino) propoxy] phenyl)-n-((1s)-2, 2, 2,-trifluoro-1-methylethyl] [1,2,4] triazolo [1,5-a] pyrimidin-7-amine salts | |
AU2003243061A1 (en) | A process for the preparation of zaleplon | |
WO2006070244A3 (en) | A process for the preparation of zaleplon | |
HUP0400325A3 (en) | Pure n-[3-(-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethyl-acetamide, process for its preparation and intermediates | |
MX2009004636A (en) | Amorphous form of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazol o [1,5-a]pyrimidin-7-yl]-phenyl-n-methyl-acetamide. | |
ZA200901289B (en) | Process and intermediates for the synthesis of (3-alkyl-5-piperidin-1-yl-3,3a-dihydro-pyrazolo[1,5-a]pyrimidin-7-yl)-amino derivatives and intermediates |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07858966 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07858966 Country of ref document: EP Kind code of ref document: A2 |